Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-10

Clinical Trial Update: Duration of ANtibiotic Therapy for CEllulitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the optimal duration of antibiotic therapy for cellulitis and erysipelas has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Cellulitis, Erysipelas | Phase 4 | Status: TERMINATED